How to improve the informed consent process

Pediatric Blood and Cancer

Volumn 55, Issue 1, 2010, Pages 10-11

  Masera, Giuseppe ^a   D'Angio, Giulio ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; DECISION MAKING; DOCTOR PATIENT RELATION; HUMAN; INFORMED CONSENT; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

CHILD; COMMUNICATION; HUMANS; INFORMED CONSENT; PARENTS; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RESEARCH;

EID: 77953257218     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22560     Document Type: Note

References (8)

1. Berger O, Grønberg BH, Sand K, et al. The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol 2009;20:379-385.
2. Beardsley E, Jefford M, Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: So why are they lengthening? J Clin Oncol 2007;25:e13-e14.
3. Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Informed consent - Why are its goals imperfectly realized? N Engl J Med 1980;302:896-900.
4. Evans AE. The myth of informed consent. J Pediatr Hematol Oncol 2001;23:74.
5. Syse A. Norway: Valid (as opposed to informed) consent. Lancet 2000;356:1347-1348.
6. Wiley FM, Ruccione K, Moore IM, et al. Parents' perceptions of randomization in pediatric clinical trials. Cancer Pract 1999;7:248-256.
7. Jefford M, Moore R. Improvement of informed consent and the quality of consent documents. Lancet Oncol 2008;9:485-493.
8. Masera G, Beltrame F, Corbetta A, et al. Audiotaping communication of the diagnosis of childhood leukemia: Parents' evaluation. J Pediatr Hematol Oncol 2003;25:368-371.